ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone510-279-4262
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees162
Next Earnings Date11/4/2019 (Estimated)
OptionableNot Optionable
Shockwave Medical (NASDAQ:SWAV) Frequently Asked Questions
What is Shockwave Medical's stock symbol?
Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV."
How were Shockwave Medical's earnings last quarter?
Shockwave Medical Inc (NASDAQ:SWAV) posted its earnings results on Monday, August, 5th. The company reported ($0.38) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.55) by $0.17. The firm earned $10 million during the quarter, compared to analyst estimates of $8.29 million. The company's revenue was up 334.8% on a year-over-year basis. View Shockwave Medical's Earnings History.
When is Shockwave Medical's next earnings date?
What guidance has Shockwave Medical issued on next quarter's earnings?
Shockwave Medical updated its FY 2019 earnings guidance on Monday, August, 5th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $38-40 million, compared to the consensus revenue estimate of $35.39 million.
What price target have analysts set for SWAV?
4 analysts have issued 12-month target prices for Shockwave Medical's stock. Their predictions range from $32.00 to $65.00. On average, they expect Shockwave Medical's share price to reach $43.50 in the next twelve months. This suggests a possible upside of 9.8% from the stock's current price. View Analyst Price Targets for Shockwave Medical.
What is the consensus analysts' recommendation for Shockwave Medical?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Shockwave Medical.
Has Shockwave Medical been receiving favorable news coverage?
News stories about SWAV stock have been trending positive recently, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Shockwave Medical earned a daily sentiment score of 2.5 on InfoTrie's scale. They also gave headlines about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the company's share price in the next several days. View News Stories for Shockwave Medical.
Are investors shorting Shockwave Medical?
Shockwave Medical saw a increase in short interest in July. As of July 15th, there was short interest totalling 2,672,100 shares, an increase of 6.1% from the June 15th total of 2,519,400 shares. Based on an average daily trading volume, of 486,600 shares, the short-interest ratio is presently 5.5 days. Approximately 13.7% of the company's shares are short sold. View Shockwave Medical's Current Options Chain.
Who are some of Shockwave Medical's key competitors?
Some companies that are related to Shockwave Medical include Tandem Diabetes Care (TNDM), Cantel Medical (CMD), ICU Medical (ICUI), NuVasive (NUVA), Nevro (NVRO), Glaukos (GKOS), Merit Medical Systems (MMSI), Irhythm Technologies (IRTC), Cardiovascular Systems (CSII), Atrion (ATRI), Silk Road Medical (SILK), AtriCure (ATRC), Orthofix Medical (OFIX), Cryolife (CRY) and Axonics Modulation Technologies (AXNX).
What other stocks do shareholders of Shockwave Medical own?
Who are Shockwave Medical's key executives?
Shockwave Medical's management team includes the folowing people:
- Mr. Douglas E. Godshall, CEO, Pres & Director (Age 54)
- Mr. Daniel Puckett, CFO & Sec. (Age 55)
- Mr. Isaac Zacharias, Chief Commercial Officer (Age 44)
- Mr. Daniel Hawkins, Founder and Sr. Advisor (Age 52)
- Mr. John M. Adams, Co-Founder and Technical Advisor (Age 72)
When did Shockwave Medical IPO?
(SWAV) raised $75 million in an initial public offering on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.
When does Shockwave Medical's lock-up period expire?
Shockwave Medical's lock-up period expires on Tuesday, September 3rd. Shockwave Medical had issued 5,700,000 shares in its initial public offering on March 7th. The total size of the offering was $96,900,000 based on an initial share price of $17.00. After the expiration of Shockwave Medical's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.
Who are Shockwave Medical's major shareholders?
Shockwave Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (7.34%), Vanguard Group Inc. (2.38%), BlackRock Inc. (1.13%), JPMorgan Chase & Co. (0.98%), Morgan Stanley (0.96%) and Jennison Associates LLC (0.71%). View Institutional Ownership Trends for Shockwave Medical.
Which major investors are selling Shockwave Medical stock?
Which major investors are buying Shockwave Medical stock?
SWAV stock was acquired by a variety of institutional investors in the last quarter, including Vanguard Group Inc., BlackRock Inc., Jennison Associates LLC, Price T Rowe Associates Inc. MD, Renaissance Technologies LLC, Morgan Stanley, Charles Schwab Investment Management Inc. and LPL Financial LLC. View Insider Buying and Selling for Shockwave Medical.
How do I buy shares of Shockwave Medical?
Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Shockwave Medical's stock price today?
One share of SWAV stock can currently be purchased for approximately $39.60.
How big of a company is Shockwave Medical?
What is Shockwave Medical's official website?
How can I contact Shockwave Medical?
Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The company can be reached via phone at 510-279-4262 or via email at [email protected]
MarketBeat Community Rating for Shockwave Medical (NASDAQ SWAV)
MarketBeat's community ratings are surveys of what our community members think about Shockwave Medical and other stocks. Vote "Outperform" if you believe SWAV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SWAV will underperform the S&P 500 over the long term. You may vote once every thirty days.
